[Na+/Ca2+ exchanger (NCX1) and cardiovascular disease].
Iwamoto
Takahiro
T
tiwamoto@cis.fukuoka-u.ac.jp
Kita
Satomi
S
D000814:Aniline Compounds / Q000627:therapeutic use; D000818:Animals; D020013:Calcium Signaling / Q000502:physiology; D002318:Cardiovascular Diseases / Q000209:etiology*; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007668:Kidney / Q000098:blood supply; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy / Q000209:etiology; D010647:Phenyl Ethers / Q000627:therapeutic use; D015427:Reperfusion Injury / Q000188:drug therapy / Q000209:etiology; D017673:Sodium Chloride, Dietary / Q000009:adverse effects; D019831:Sodium-Calcium Exchanger / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D013890:Thiourea / Q000031:analogs & derivatives / Q000627:therapeutic use
C101670:2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate; D000814:Aniline Compounds; D010647:Phenyl Ethers; C430918:SEA 0400; D017673:Sodium Chloride, Dietary; D019831:Sodium-Calcium Exchanger; C110374:sodium-calcium exchanger 1; D013890:Thiourea